PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Loratadine - Allergic rhinitis
PAD Profile : Loratadine - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Clarityn allergy
Traffic Light Status
Status 1 of 2.
Status :
Green
Preferred
Formulations :
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Green
Important
Preferred
Formulations :
- Oral solution
Important Information :
Loratadine 5mg/5ml oral solution sugar free is the preferred option in patients unable to swallow tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Cetirizine hydrochloride
- Desloratadine
- Levocetirizine
- Bilastine
- Mizolastine
- Acrivastine
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
GENERIC loratadine has been considered by the APC and has been agreed as a 1st line treatment option
Available to purchase
Liquids reserved for patients unable to swallow solid dose forms.
Loratadine liquid (5mg/5ml) suger free is the 1st-line choice (from 2 years)
Cetirizine liquid (1mg/ml) is 2nd-line option. Safe and effective and can be prescribed from age of 2.
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines